Fertility Specialist Dr. Madeline Kaye on PCOS, Egg Freezing, and Advances in Reproductive Care
Author(s): Scott Douglas Jacobsen
Publication (Outlet/Website): A Further Inquiry
Publication Date (yyyy/mm/dd): 2025/10/31
Dr. Madeline Kaye is a fertility specialist at the Texas Fertility Center who helps individuals and couples start and grow their families. Using advanced fertility treatments and personalized care plans, she diagnoses and treats the complex causes of infertility. With experience working as both an OB/GYN and later a fertility specialist, Dr. Kaye offers a comprehensive approach to women’s and reproductive healthcare. Although she cares for patients facing all types of infertility, she is especially passionate about providing integrated care for polycystic ovary syndrome (PCOS) and egg freezing patients. Her goal is to offer world-class care and compassion while empowering patients on the path to parenthood.
In this interview with Scott Douglas Jacobsen, Dr. Kaye highlights the importance of multidisciplinary care, mental health support, and emerging technologies, such as AI and stem cell research, in shaping the future of reproductive medicine.
Scott Douglas Jacobsen: How do you help women with PCOS improve fertility outcomes?
Dr. Madeline Kaye: PCOS affects fertility primarily through two mechanisms: hormonal miscommunication between the brain and ovaries, and insulin resistance. Both contribute to irregular ovulation, the biggest barrier to conception. Because of this, treatment is multifaceted. We focus on lifestyle strategies—nutrition, exercise, sleep, and stress management—that strongly influence hormonal and metabolic health. Depending on individual needs, we may also recommend supplements or medications to improve insulin sensitivity. When ovulation remains a challenge, fertility-specific medications can help restore hormonal signaling and increase the chances of pregnancy.
Jacobsen: What are the most effective fertility treatments for PCOS patients?
Kaye: For some women with PCOS, lifestyle changes alone can be enough to restore ovulation. But many need additional support, and this is where fertility medications are highly effective. The most common first-line treatment is letrozole (Femara), which stimulates egg growth and maturation by altering estrogen signaling in the brain. Letrozole can be used alone or combined with intrauterine insemination (IUI) to improve success rates. In other cases, in vitro fertilization (IVF) may be recommended. IVF is often particularly successful in women with PCOS, since they usually have a higher egg reserve, allowing for more opportunities to create healthy embryos.
Jacobsen: How can lifestyle changes complement fertility treatments when there is polycystic ovary syndrome?
Kaye: Lifestyle changes are a powerful way to support fertility for women with PCOS. By improving insulin resistance and promoting hormonal balance, they can help restore more regular ovulation—and for some, this may be enough to achieve pregnancy without additional treatment. Even when medications or procedures are needed, a foundation of healthy eating, regular movement, adequate sleep, and stress management not only enhances treatment effectiveness but also supports long-term reproductive and overall health.
Jacobsen: What barriers exist in receiving early diagnosis and treatment for PCOS-related infertility?
Kaye: PCOS is complex and looks different for every patient, which can make diagnosis challenging. Many healthcare providers have limited training in PCOS or lack the time and resources to provide comprehensive, multidisciplinary care. In addition, education about what a normal menstrual cycle looks like is often insufficient. As a result, women may not realize their cycles are irregular—or that PCOS could be the underlying cause—leading to delays in both diagnosis and treatment.
Jacobsen: How does integrated, multidisciplinary care improve fertility success?
Kaye: Because lifestyle factors are central to managing PCOS, a multidisciplinary approach offers the best outcomes. In my practice, I often collaborate with dietitians, and ideally every patient would also have access to fitness professionals, mental health providers, and dermatologists. This team-based care ensures patients receive comprehensive support—addressing not just ovulation and fertility, but overall well-being.
Jacobsen: What role does mental health support play in fertility treatment?
Kaye: Mental health support is essential, yet too often overlooked. Infertility is an incredibly stressful journey, and chronic stress can worsen hormonal imbalances by raising cortisol levels. Having strong emotional support—whether from loved ones or mental health professionals—can make a meaningful difference. Practices like therapy, meditation, yoga, or other stress-reducing activities not only help patients cope but may also support better hormonal regulation and fertility outcomes.
Jacobsen: How are you advancing reproductive care for women with complex fertility conditions?
Kaye: I prioritize understanding each patient’s individual goals and concerns, then tailoring care accordingly. We dedicate time to addressing lifestyle factors that influence fertility while integrating evidence-based medical treatments. Collaborating with other specialists allows us to deliver more comprehensive, personalized care and maximize the chances of success for women facing complex fertility challenges.
Jacobsen: What emerging technologies and treatments shape the future of fertility care?
Kaye: Fertility care is rapidly evolving, with new technologies expanding what’s possible. Artificial intelligence is being harnessed to improve patient counseling, embryo and sperm selection, and treatment planning. IVF laboratories are becoming increasingly automated, reducing errors and potentially improving access. Researchers are exploring stem cell therapies to regenerate eggs, as well as novel diagnostic tools to better evaluate the endometrium and implantation. These innovations hold promise for making fertility care more precise, effective, and widely accessible in the future.
Jacobsen: Thank you for the opportunity and your time, Dr. Kaye.
Last updated May 3, 2025. These terms govern all In-Sight Publishing content—past, present, and future—and supersede any prior notices. In-Sight Publishing by Scott Douglas Jacobsen is licensed under a Creative Commons BY‑NC‑ND 4.0; © In-Sight Publishing by Scott Douglas Jacobsen 2012–Present. All trademarks, performances, databases & branding are owned by their rights holders; no use without permission. Unauthorized copying, modification, framing or public communication is prohibited. External links are not endorsed. Cookies & tracking require consent, and data processing complies with PIPEDA & GDPR; no data from children < 13 (COPPA). Content meets WCAG 2.1 AA under the Accessible Canada Act & is preserved in open archival formats with backups. Excerpts & links require full credit & hyperlink; limited quoting under fair-dealing & fair-use. All content is informational; no liability for errors or omissions: Feedback welcome, and verified errors corrected promptly. For permissions or DMCA notices, email: scott.jacobsen2025@gmail.com. Site use is governed by BC laws; content is “as‑is,” liability limited, users indemnify us; moral, performers’ & database sui generis rights reserved.
In-Sight Publishing 